StockData
Pluri Inc. logo

Pluri Inc. (PLUR) stock

PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.92−0.06 (-6.62%)

Close on Nov 18, 2026Market cap $11.30MP/E –Yield –

Pluri shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Pluri's shares outstanding was 11M at Jun 30, 2026. For fiscal 2026 it was 10M, up 53.8% from the year before. Over ten years it grew 25.6% a year on average. The highest annual figure on record is 10M in fiscal 2026.

Annual shares outstanding

PeriodPeriod endValueChange
FY2026Jun 30, 202610M+53.8%
FY2025Jun 30, 20256M+20.9%
FY2024Jun 30, 20245M+14.4%
FY2023Jun 30, 20235M+13.9%
FY2022Jun 30, 20224M+14.5%
FY2021Jun 30, 20214M+54.5%
FY2020Jun 30, 20202M+47.6%
FY2019Jun 30, 20192M+16.5%
FY2018Jun 30, 20181M+21.1%
FY2017Jun 30, 20171M+9.9%
FY2016Jun 30, 20161M+13.2%
FY2015Jun 30, 20151M+10.7%
FY2014Jun 30, 20141M+14.5%
FY2013Jun 30, 20131M+26.0%
FY2012Jun 30, 20121M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 202611M+37.4%
Q3 FY2026CQ1 2026Mar 31, 202610M+53.2%
Q2 FY2026CQ4 2025Dec 31, 20259M+66.8%
Q1 FY2026CQ3 2025Sep 30, 20259M+64.8%
Q4 FY2025CQ2 2025Jun 30, 20258M+44.5%
Q3 FY2025CQ1 2025Mar 31, 20257M+25.7%
Q2 FY2025CQ4 2024Dec 31, 20246M+7.0%
Q1 FY2025CQ3 2024Sep 30, 20245M+5.7%
Q4 FY2024CQ2 2024Jun 30, 20245M+5.1%
Q3 FY2024CQ1 2024Mar 31, 20245M+4.6%
Q2 FY2024CQ4 2023Dec 31, 20235M+25.1%
Q1 FY2024CQ3 2023Sep 30, 20235M+26.9%
Q4 FY2023CQ2 2023Jun 30, 20235M+26.5%
Q3 FY2023CQ1 2023Mar 31, 20235M+23.8%
Q2 FY2023CQ4 2022Dec 31, 20224M+3.3%
Q1 FY2023CQ3 2022Sep 30, 20224M+1.8%
Q4 FY2022CQ2 2022Jun 30, 20224M+2.3%
Q3 FY2022CQ1 2022Mar 31, 20224M+8.9%
Q2 FY2022CQ4 2021Dec 31, 20214M+25.2%
Q1 FY2022CQ3 2021Sep 30, 20214M+25.3%
Q4 FY2021CQ2 2021Jun 30, 20214M+33.7%
Q3 FY2021CQ1 2021Mar 31, 20214M+66.2%
Q2 FY2021CQ4 2020Dec 31, 20203M+61.1%
Q1 FY2021CQ3 2020Sep 30, 20203M+65.8%
Q4 FY2020CQ2 2020Jun 30, 20203M+61.3%
Q3 FY2020CQ1 2020Mar 31, 20202M+52.0%
Q2 FY2020CQ4 2019Dec 31, 20192M+37.6%
Q1 FY2020CQ3 2019Sep 30, 20192M+35.5%
Q4 FY2019CQ2 2019Jun 30, 20192M+31.9%
Q3 FY2019CQ1 2019Mar 31, 20191M+6.5%
Q2 FY2019CQ4 2018Dec 31, 20181M+10.1%
Q1 FY2019CQ3 2018Sep 30, 20181M+16.8%
Q4 FY2018CQ2 2018Jun 30, 20181M+15.8%
Q3 FY2018CQ1 2018Mar 31, 20181M+19.9%
Q2 FY2018CQ4 2017Dec 31, 20171M+29.7%
Q1 FY2018CQ3 2017Sep 30, 20171M+20.6%
Q4 FY2017CQ2 2017Jun 30, 20171M–
Q3 FY2017CQ1 2017Mar 31, 20171M–
Q2 FY2017CQ4 2016Dec 31, 20161M–
Q1 FY2017CQ3 2016Sep 30, 20161M–

More Pluri figures

See a number that looks wrong?